secwatch.observer — SEC 8-K summary
======================================

Issuer:     C4 Therapeutics, Inc. (CCCC)
CIK:        0001662579
Form:       8-K
Filed at:   2024-01-11T23:59:59+00:00
Accession:  0001628280-24-001085
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

C4 Therapeutics posts investor presentation; announces restructuring to preserve cash runway into 2027
--------------------------------------------------------------------------------

- Company posted investor presentation on January 11, 2024, detailing a restructuring plan.
- Restructuring expected to preserve cash runway into 2027.
- Estimated charges and costs for restructuring to be incurred in connection with cost-saving initiatives.
- Forward-looking statements include expectations on timing, costs, and efficiencies from the restructuring.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662579/000162828024001085/0001628280-24-001085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662579/000162828024001085/cccc-20240111.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-001085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer